A new and revised Strategic Framework for Collaboration between the World Health Organisation (WHO) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund) was signed to strengthen more resilient healthcare systems and to maximize cooperation and affect in the support of national, regional, and international responses for major infectious diseases.
Word Health Organisation Reported that the new 5-year framework expands upon the 2018 agreement. It is consistent with the World Health Organization’s General Programme of Work and the 2023–2028 Global Fund Strategy, prioritizing community engagement in health responses and addressing problems like preparedness for pandemics or climate change and the framework is compatible with larger platforms for collaboration that aim to enable nations to achieve health connected Sustainable Development (SDGs) with universal health coverage (UHC).
As healthcare budgets worldwide are stretched & under pressure, our 2 organizations must continue to collaborate to support nations as they work to achieve universal health coverage by assisting them in expanding access to treatments for the three diseases. Stronger cooperation between the World Health Organization and the Global Fund is required now more than ever because of the decreasing progress in eradicating the AIDS, TB, and malaria epidemics as well as new health problems.
The updated Strategy Plan for Cooperation will enhance collaboration in light of WHO and the Global Fund’s shared mission and dedication to serving countries. The cooperation between the Global Fund and WHO is more important than ever when the globe is plagued by interconnected and intersecting crises, ranging from war to climate change, according to Peter Sands, executive director of the Global Fund.
The most vulnerable individuals suffer the most due to crises, which upset global institutions and reverse advancements. To develop local, community-driven health systems, organizations like ours are most effective when we work directly with federal and state governments and other reliable partners.
Continuous cooperation over the last few years has helped to accomplish substantial successes at the national level: Twenty nations are implementing differentiated delivery systems for HIV testing, therapy, advanced HIV disease treatment, and even online interventions for those unsure of their HIV status more effectively and economically. Through initial advice and polls on double testing for COVID-19 & TB, collaboration has made it possible to identify better persons with TB thanks to the innovations used both during and after the COVID-19 emergency.
The elimination of malaria has advanced more quickly, thanks to strategic actions. WHO has granted eight nations its accreditation as malaria-free since 2018; five more are gearing up to receive it in 2023 and 2024. The alliance also lays the groundwork for accelerating the adoption of novel strategies, like expanding new, quicker treatments for multidrug-resistant TB and the new WHO Insecticides Treatment Nets Guideline for malaria.
Creating 50 national strategic plans with cost estimates aligned with the most recent WHO recommendations received significant assistance and served as the foundation for solid funding submissions to the Global Fund. Even with such a level of growth, nations still have a long way to go in accelerating the end of the AIDS, TB, and malaria epidemics and developing robust health systems, that can also handle the subsequent crises.
